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PURPOSE: Catastrophic antiphospholipid syndrome (CAPS), the most severe
manifestation of antiphospholipid syndrome (APS), is characterised by simultaneous
thromboses in multiple organs. Diagnosing CAPS can be challenging but its early
recognition and management is crucial for a favourable outcome. This study was
undertaken to evaluate the frequencies, distributions and ability to predict mortality of
"definite/probable" or "no-CAPS" categories of thrombotic APS patients requiring
admission to the intensive care unit (ICU).
METHODS: This French national multicentre retrospective study, conducted from
January 2000 to September 2018, included all APS patients with any new thrombotic
manifestation(s) admitted to 24 ICUs.
RESULTS: One hundred and thirty-four patients (male/female ratio: 0.4; mean age at
admission: 45.4 ± 15.0 years), who experienced 152 CAPS episodes, required ICU
admission. The numbers of definite, probable or no-CAPS episodes, respectively, were:
11 (7.2%), 60 (39.5%) and 81 (53.3%). No histopathological proof of microvascular
thrombosis was the most frequent reason for not being classified as definite CAPS.
Overall, 35/152 (23.0%) episodes were fatal, with comparable rates for
definite/probable CAPS and no CAPS (23% vs. 28.8% respectively, p = 0.4). The
Kaplan-Meier curve of estimated probability of survival showed no between-group
survival difference (log-rank test p = 0.5).
CONCLUSIONS: In this study, CAPS criteria were not associated with mortality of
thrombotic APS patients requiring ICU admission. Further studies are need evaluate
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